In this webinar, leaders of Husch Blackwell’s Psychedelics and Emerging Therapies practice will discuss a variety of topics relevant to businesses, clinicians, and researchers working with psychedelics or seeking to expand their practice to include these medicines.
Topics
- Overview of state and federal law
- Advanced Integrative Medical Science Institute v. Drug Enforcement Administration petition to reschedule psilocybin
- Practical employment law considerations and updates
- Discussion of risk mitigation strategies as the industry matures
- New draft of FDA guidance for psychedelic clinical trials
Presenters
Karen Luong, Partner
Chris Miles, Partner
Natasha Sumner, Attorney
Who Should Attend
Hospital business development professionals, C-suite executives, higher education general counsel, researchers, healthcare clinicians, and practitioners interested in or conducting clinical trial work with controlled substances.
Continuing Education Credit
This program is pending approval for Colorado, Illinois, Iowa, Kansas, Missouri, Nebraska, Tennessee, Texas, and Wisconsin continuing legal education credit.
Sean Hocking
Source link
